Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Mauri

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 miceSarah Lawman, Claudia Mauri, Elizabeth C Jury, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Type I IFN protects permissive macrophages from Legionella pneumophila infection through an IFN-gamma-independent pathwayGiovanna Schiavoni, Claudia Mauri, Davide Carlei, et al.
Immunity|March 13, 2012
Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cellsAnneleen Bosma, Azza Abdel-Gadir, David A Isenberg, et al.
Arthritis Research & Therapy|January 21, 2017
TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patientsOctavio Aravena, Ashley Ferrier, Madhvi Menon, et al.
Clinical Immunology (Orlando, Fla.)|August 2, 2015
Regulatory B cells in CVID patients fail to suppress multifunctional IFN-γ+ TNF-α+ CD4+ T cells differentiationMarcela Vlkova, Olga Ticha, Jana Nechvatalova, et al.
Annals of the Rheumatic Diseases|March 30, 2019
Presence of anti-rituximab antibodies predicts infusion-related reactions in patients with systemic lupus erythematosusChris Wincup, Madhvi Menon, Edward Smith, et al.
The Journal of Experimental Medicine|July 29, 2004
Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapyMichael R Ehrenstein, Jamie G Evans, Animesh Singh, et al.
Science Translational Medicine|February 22, 2013
CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiationFabian Flores-Borja, Anneleen Bosma, Dorothy Ng, et al.
Arthritis and Rheumatism|June 8, 2012
Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapyJenny L McGovern, Dao X Nguyen, Clare A Notley, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2004
Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosisClaudia Monaco, Evangelos Andreakos, Serafim Kiriakidis, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 miceSarah Lawman, Claudia Mauri, Elizabeth C Jury, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Type I IFN protects permissive macrophages from Legionella pneumophila infection through an IFN-gamma-independent pathwayGiovanna Schiavoni, Claudia Mauri, Davide Carlei, et al.
Immunity|March 13, 2012
Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cellsAnneleen Bosma, Azza Abdel-Gadir, David A Isenberg, et al.
Arthritis Research & Therapy|January 21, 2017
TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patientsOctavio Aravena, Ashley Ferrier, Madhvi Menon, et al.
Clinical Immunology (Orlando, Fla.)|August 2, 2015
Regulatory B cells in CVID patients fail to suppress multifunctional IFN-γ+ TNF-α+ CD4+ T cells differentiationMarcela Vlkova, Olga Ticha, Jana Nechvatalova, et al.
Annals of the Rheumatic Diseases|March 30, 2019
Presence of anti-rituximab antibodies predicts infusion-related reactions in patients with systemic lupus erythematosusChris Wincup, Madhvi Menon, Edward Smith, et al.
The Journal of Experimental Medicine|July 29, 2004
Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapyMichael R Ehrenstein, Jamie G Evans, Animesh Singh, et al.
Science Translational Medicine|February 22, 2013
CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiationFabian Flores-Borja, Anneleen Bosma, Dorothy Ng, et al.
Arthritis and Rheumatism|June 8, 2012
Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapyJenny L McGovern, Dao X Nguyen, Clare A Notley, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2004
Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosisClaudia Monaco, Evangelos Andreakos, Serafim Kiriakidis, et al.
Pageof 9